News
-
-
PRESS RELEASE
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Zomedica Corp. and Boehringer Ingelheim Animal Health Canada Inc. collaborate to enhance early detection of pituitary pars intermedia dysfunction (PPID) in horses across Canada, driving recurring diagnostic revenue -
-
PRESS RELEASE
Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation
Zomedica Corp. announces webinar on international expansion strategy, distributor network, global market opportunities, and commercial leadership across five continents -
-
PRESS RELEASE
Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity
Zomedica reports record $9 million revenue in Q2 2026, marking 22 consecutive quarters of growth. Expansion in international markets and strong product portfolio drive success -
-
-
-
PRESS RELEASE
Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic
Zomedica Corp. announces webinar on its specialized sales organization's role in product adoption and revenue growth. Investors to gain insight into the Company's structure and strategies
